COMP <GO>
SCL vs PG // RSI-14 & 200D SMA MOMENTUM
Stepan Company (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: SCL 3
— PG 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: SCL
LAST: $69.99 (+2.31%) • MKT CAP: $1.59B
rsi-technicals
77.1
LAST: $160.59 (+1.47%) • MKT CAP: $372.21B
rsi-technicals
60.3
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SCL VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SCL | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 11.60% | 51.20% | -39.60 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.30% | 25.40% | -21.10 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.8x | 16.2x | -6.40 | SCL | /valuation <GO> |
| Free Cash Flow Yield | 1.59% | 3.77% | -2.18 | PG | /fcf-yield <GO> |
| Operating Margin | 3.40% | 24.30% | -20.90 | PG | /operating-margins <GO> |
| Net Profit Margin | 2.00% | 19.00% | -17.00 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 7.00% | 0.30% | +6.70 | SCL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.20% | 2.65% | -0.45 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.59 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 77.1 | 60.3 | +16.80 | SCL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.5x | 21.7x | +9.80 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.59B | $372.21B | -$370.62B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SCL REV | PG REV | SCL GROSS % | PG GROSS % | SCL FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.33B | $84.28B | 11.6% | 51.2% | $25.4M | $14.04B |
| FY 2024 | $2.18B | $84.04B | 12.5% | 51.4% | $39.3M | $16.52B |
| FY 2023 | $2.33B | $82.01B | — | — | $174.9M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SCL // BETA —
PG // BETA 0.87